These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 8850147)

  • 41. Case report: gastrointestinal haemorrhage from jejunal diverticulosis, probably induced by low dose aspirin.
    Kaushik SP; D'Rozario JM; Chong G; Bassett ML
    J Gastroenterol Hepatol; 1996 Oct; 11(10):908-10. PubMed ID: 8912125
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Ulcers and gastritis.
    Pang SH; Leung WK; Graham DY
    Endoscopy; 2008 Feb; 40(2):136-9. PubMed ID: 18058616
    [No Abstract]   [Full Text] [Related]  

  • 43. Reduced risk of upper gastrointestinal ulcer complications with celecoxib, a novel COX-2 inhibitor.
    Goldstein JL; Silverstein FE; Agrawal NM; Hubbard RC; Kaiser J; Maurath CJ; Verburg KM; Geis GS
    Am J Gastroenterol; 2000 Jul; 95(7):1681-90. PubMed ID: 10925968
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [When the cardiac patient with arthritis needs aspirin and NSAID: how to protect the stomach?].
    Zeidler H
    MMW Fortschr Med; 2003 Jan; 145(5):8. PubMed ID: 12619198
    [No Abstract]   [Full Text] [Related]  

  • 45. [Secondary and primary prophylaxis of gastropathy associated with nonsteroidal antiinflammatory drugs or low-dose-aspirin: a review based on four clinical scenarios].
    Limmer S; Ittel TH; Wietholtz H
    Z Gastroenterol; 2003 Aug; 41(8):719-28. PubMed ID: 12910426
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A rare complication of jejunal diverticulosis.
    Shanmugam RP; Shivakumar P
    Trop Gastroenterol; 2006; 27(3):134-5. PubMed ID: 17310558
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Preventive therapy for non-steroidal anti-inflammatory drug-induced ulcers in Japanese patients with rheumatoid arthritis: the current situation and a prospective controlled-study of the preventive effects of lansoprazole or famotidine.
    Miyake K; Ueki N; Suzuki K; Shinji Y; Kusunoki M; Hiratsuka T; Nishigaki H; Tatsuguchi A; Futagami S; Wada K; Tsukui T; Nakajima A; Yoshino S; Sakamoto C
    Aliment Pharmacol Ther; 2005 Jun; 21 Suppl 2():67-72. PubMed ID: 15943850
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Reintroduction of anti-inflammatory drug therapy after drug-associated gastro-intestinal disturbances.
    Bunton RW; Barrett DC; Palmer DG
    N Z Med J; 1982 Aug; 95(714):582-4. PubMed ID: 6982441
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Outcome of peptic ulcer bleeding among users of traditional non-steroidal anti-inflammatory drugs and selective cyclo-oxygenase-2 inhibitors.
    Thomsen RW; Riis A; Christensen S; McLaughlin JK; Sørensen HT
    Aliment Pharmacol Ther; 2006 Nov; 24(10):1431-8. PubMed ID: 17032286
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Severe neutropenia due to naproxen therapy in rheumatoid arthritis: a case report and review of literature.
    Kalksma R; Jansen TL; Bruyn GA
    Neth J Med; 2002 Aug; 60(7):289-91. PubMed ID: 12430576
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prevalence of Helicobacter pylori in NSAID users with gastric ulcer.
    Matsukawa Y; Aoki M; Nishinarita S; Sawada S; Horie T; Kato K; Kawamura Y; Kawamura F; Arakawa Y; Kurosaka H; Morita K; Ohtsuka E; Oribe M; Nakano M; Kitami Y
    Rheumatology (Oxford); 2003 Aug; 42(8):947-50. PubMed ID: 12730504
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Celecoxib compared with lansoprazole and naproxen to prevent gastrointestinal ulcer complications.
    Lai KC; Chu KM; Hui WM; Wong BC; Hu WH; Wong WM; Chan AO; Wong J; Lam SK
    Am J Med; 2005 Nov; 118(11):1271-8. PubMed ID: 16271912
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Enteroscopic diagnosis of small bowel ulceration in patients receiving non-steroidal anti-inflammatory drugs.
    Morris AJ; Madhok R; Sturrock RD; Capell HA; MacKenzie JF
    Lancet; 1991 Mar; 337(8740):520. PubMed ID: 1671893
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Non-NSAID non-H. pylori ulcer disease.
    Chow DK; Sung JJ
    Best Pract Res Clin Gastroenterol; 2009; 23(1):3-9. PubMed ID: 19258182
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Extended poststrangulation ischemic jejunal stricture.
    Ghidirim G; Mishin I; Vozian M; Zastavnitsky G
    J Gastrointestin Liver Dis; 2008 Mar; 17(1):114-5. PubMed ID: 18392260
    [No Abstract]   [Full Text] [Related]  

  • 56. [How to reduce the risks of NSAIDs].
    Gross M
    MMW Fortschr Med; 2008 Jul; 150(28-31):50-3; quiz 54. PubMed ID: 19006892
    [No Abstract]   [Full Text] [Related]  

  • 57. Non-steroidal anti-inflammatory drug-induced gastroduodenal toxicity and Helicobacter pylori.
    Wardi J; Shirin H
    Isr Med Assoc J; 2003 Mar; 5(3):195-7. PubMed ID: 12725142
    [No Abstract]   [Full Text] [Related]  

  • 58. The COX 2 selective inhibitors: what the newspapers have not told you.
    Simon LS
    Bull NYU Hosp Jt Dis; 2007; 65(3):229-41. PubMed ID: 17922675
    [No Abstract]   [Full Text] [Related]  

  • 59. Nonsteroidal anti-inflammatory drugs, Helicobacter pylori, and ulcers: where we stand.
    Graham DY
    Am J Gastroenterol; 1996 Oct; 91(10):2080-6. PubMed ID: 8855725
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Primary ulcerations of the small intestine].
    Marsepoil T; Caban J; Levesque P; Bertaux M; Blin F
    J Chir (Paris); 1989; 126(8-9):463-5. PubMed ID: 2808561
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.